Open to Ohio
In November 2025, Tokyo-based telecommunications company SoftBank announced $3 billion plans to reimagine a former General Motors assembly plant in northeastern Ohio, originally acquired by Foxconn in 2022. The company will transform the facility in Lordstown to begin manufacturing equipment for future OpenAI data centers. This initiative follows the September announcement from SoftBank, OpenAI and Oracle for the $500 billion Stargate project, which will introduce five new AI data centers in the U.S. by 2029. The facility will produce modular data centers, portable, preassembled units to streamline deployment and scalability. Production is slated to begin in 2026.
Once operational, Zoetis will create 100 new jobs in the region.
Photo: Getty Images
Strategic Portfolio Expansion Hits Georgia
About 30 minutes west of Atlanta, animal health company Zoetis is in the midst of constructing a new monoclonal antibody and vaccine manufacturing facility in Douglasville. The $590 million investment comes as part of the company’s greater $1.3 billion U.S. portfolio expansion, which includes new locations in California, Nebraska, Iowa, Illinois, Michigan and North Carolina. Zoetis has stated the Georgia facility is about 70% complete and is expected to become operational by 2029. Designed to be a technology and digital innovation hub, the site will feature VR training, collaborative robots and advanced Manufacturing Execution Systems.
Saronic’s expansion project will be supported by a $2 million performance-based grant and $3 million from the state’s Economic Development Award Program.
Photo courtesy of Saronic
Autonomous Ships Prefer the Gulf Coast
By the start of 2027, Saronic Technologies will ramp up operations at its expanded autonomous surface vessels shipyard in St. Mary Parish, Louisiana. The new $300 million investment will bring 300,000 sq. ft. of additional capacity to the company’s current Franklin site. Project details include the construction of three new slips, a warehouse expansion and a new large-vessel assembly production line. Ships produced at the site will directly support growing demand for autonomous vessels across the defense and commercial sectors, creating 1,500 new direct jobs.
Invest Ontario is supporting the new investment with up to $12 million from the Invest Ontario Fund.
Photo courtesy of Marvell Technology
Growth Favors Ontario
Delaware-based semiconductor equipment manufacturer Marvell Technology has committed to pursue a $170 million, five-year expansion throughout Ontario. In the official release it was noted that Marvell will open a new office in Toronto, expand its R&D facilities in Ottawa and York and construct a new 8,000-sq.-ft. optical lab in the region. “We considered several locations to expand our operations and Ontario’s talent stood out as one of the biggest draws,” said Marvell Data Center Group President Sandeep Bharathi. This expansion follows rising demand for the company’s custom AI silicon and connectivity solutions for data center developers. By 2030, Marvell will create 350 new jobs in the province.
The new API facility will support growing demand for the company’s growing product portfolio.
Photo courtesy of Celltrion
Bring In Celltrion
A South Korea-based pharmaceutical company has said it will invest $478 million to revamp a former Eli Lilly and Company facility in Somerset County, New Jersey. Celltrion has plans to focus on active pharmaceutical ingredient manufacturing at the Branchburg facility, which it had acquired for $330 million in late 2025. In a regulatory filing in December, the company noted new U.S. pharmaceutical tariff policies as a driving force behind the investment.
